Underwriters Laboratories certified the product on January 22, 2009 opening the way to customer deliveries of FreeHand throughout Europe and those other countries whose certification or licensing requirements are based on the CE Mark.
FreeHand is said to be the first product in Prosurgics’s new generation of affordable surgical robotics. Suitable for every laparoscopic procedure, it provides superior visualization and the ability for surgeons to directly control movement of the scope, by means of Prosurgics’s patented ‘surgeon head movement’ interface, the company said.
Paul Moraviec, CEO of Prosurgics, said: Gaining the CE Mark moves Prosurgics to the next phase of our commercialization plan. Surgeons throughout Europe are telling our sales teams that FreeHand addresses their real and unmet needs.
With our production volumes ramping up, we are now in a position that we can satisfy this demand and so I expect to see a rapidly growing number of FreeHand surgeons over the next weeks and months. With many US surgeons also wanting to share in the benefits of FreeHand, we look forward to the FDA clearance following soon.